Posts in Uncategorized

Screenin3D microfluidic technology for cancer therapy assessment is published in the May issue of IEEE Open Journal of Engineering in Medicine and Biology

May 23rd, 2022 Posted by Uncategorized 0 thoughts on “Screenin3D microfluidic technology for cancer therapy assessment is published in the May issue of IEEE Open Journal of Engineering in Medicine and Biology”

“CAR-T cell development is expensive and patient-derived tissue is a limited resource. Our aim is to enable 20 to 50 times more experiments to be performed in these conditions.” – Dr M Zagnoni, CEO of Screenin3D

 

Miniaturisation and increased throughput in screening are key to a faster, more cost-effective delivery of cancer therapies from bench to bedside. In a new publication in IEEE Open Journal of Engineering in Medicine and Biology, Screenin3D OncoChip3D microfluidic platform was used to test the cytotoxicity of CAR-T cells and combination therapy on miniaturised solid cancer models.

In this publication, the technology showcases a co-culture of cancerous and stromal cells that create a physiologically relevant solid cancer model for the assessment of CAR-T, carboplatin, and anti-PD-L1 antibody therapies.

Read more about the application of OC3D Single microfluidic chip in the original publication and the EurekAlert press release 

Dr Zagnoni pitched at BioSeed 2022 early stages life sciences investment event

January 25th, 2022 Posted by Uncategorized 0 thoughts on “Dr Zagnoni pitched at BioSeed 2022 early stages life sciences investment event”

We are excited to announce that Screenin3D pitched at the BioSeed 2022 conference, a landmark investment event for early-stage companies featuring over 80 investors.

 

Our Company
Follow Us

 

© Copyright ScreenIn3D. All rights reserved 2019.
ScreenIn3D Limited registered in Scotland. Registered number SC614453